Skip to main content

Table 8 Results of the paired-samples t-tests for lipoproteins before and after treatment, by allele

From: Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response

Allele Variable
mg/dL
N Mean SD t-test p
C TotalChol 59 210.93 45.26 0.20 0.85
  TotalChol2 59 209.71 39.06   
T TotalChol 57 209.67 45.68 0.08 0.93
  TotalChol2 57 209.11 47.08   
C HDL-C 59 57.53 12.16 1.37 0.18
  HDL-C2 59 55.80 14.24   
T HDL-C 57 60.42 14.52 0.50 0.62
  HDL-C2 57 59.79 14.35   
C LDL-C 59 126.44 37.70 -0.20 0.84
  LDL-C2 59 127.44 36.44   
T LDL-C 57 113.44 38.62 -1.39 0.17
  LDL-C2 57 123.32 39.58   
C TG 59 134.47 58.15 1.85 0.07
  TG2 59 121.47 59.69   
T TG 57 141.79 71.95 2.46 0.02
  TG2 57 122.68 72.88   
  1. TotalChol: total pre-treatment cholesterol; HDL-C: pre-treatment high-density lipoprotein cholesterol; LDL-C: pre-treatment low-density lipoprotein cholesterol; TG: pre-treatment triglycerides; TotalChol2: total post-treatment cholesterol; HDL-C2: post-treatment high-density lipoprotein cholesterol; LDL-C2: post-treatment low-density lipoprotein cholesterol; TG2: post-treatment triglycerides; CC: homozygous major-allele genotype; CT: heterozygous genotype; TT: homozygous minor-allele genotype.